- No-deal Brexit disruption at UK ports could last up to six months – minister (reuters.com)
A no-deal Brexit could cause up to six months of disruption at some ports, a British minister warned...vowing to prioritise pharmaceuticals as the UK develops contingency plans less than four months before it is due to leave the EU...Health minister Matt Hancock wrote to drugs companies in August to ensure they had at least six weeks’ worth of medicines in Britain but on Friday he suggested any potential disruption could last longer...Britain is planning to use aeroplanes and fast-track trucks to ensure the continued supply of medicines if it leaves the European Union without a deal, Hancock said, and will give preference to medicines in the face of competing pressures.
- CVS offers ‘guaranteed net cost’ for pharmacy benefit clients (reuters.com)
Pharmacy chain and benefits manager CVS Health Corp...said...it will offer a new prescription benefit option guaranteeing its health plan clients 100 percent of any rebates, discounts or other fees paid by drugmakers...The new plan model is aimed at providing greater drug cost simplicity, predictability and transparency...Under its new option, CVS takes on the risk of drug price inflation and shifts in drug use - at least for the term of each contract...The new model guarantees average spending per prescription across each distribution channel – retail, mail order and specialty pharmacy...
- This Week in Managed Care: November 30, 2018 (ajmc.com)
Laura Joszt, Managing Editor at The American Journal of Managed Care. Welcome to This Week in Managed Care from the Managed Markets News Network
- November 23 Pharmacy Week in Review: FDA Approves Rifamycin for Travelers-related Illness, Study Finds Incidence of Eczema is Much Higher Than Other Inflammatory Conditions (pharmacytimes.com)
Nicole Grassano, PTNN, Pharmacy Week in Review, this weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
- December 7 Pharmacy Week in Review: Rural Health Care Workers Work Toward Policy Change, FDA Approves Treatment for Ocular Pain After Surgery (pharmacytimes.com)
Nicole Grassano, PTNN, Pharmacy Week in Review, this weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
- Antimicrobial Stewardship Programs Need Pharmacist Expertise (drugtopics.com)
As pharmacists continually build their scope of expertise, hospital anti-microbial stewardship programs are just one more avenue for putting their experience and knowledge to work...Anna Legreid Dopp, PharmD, director of clinical guidelines and quality improvement at ASHP, says pharmacists have a responsibility to take a prominent role in antimicrobial stewardship programs by
- Promoting the opial use of antimicrobial agents;
- Reducing the transmission of infections;
- Decreasing adverse events associated with antibiotic use; and
- Participating in formulary management and educating health professionals, patients, and the public.
- CVS Health Completes Acquisition of Aetna, Marking the Start of Transforming the Consumer Health Experience (cvshealth.com)CVS Completes $70 Billion Acquisition of Aetna (wsj.com)CVS-Aetna merger approved by New York regulators (nypost.com)
CVS Health...today announced that it has completed its acquisition of Aetna...“Today marks the start of a new day in health care and a transformative moment for our company and our industry,” declared CVS Health President and Chief Executive Officer Larry J. Merlo. “By delivering the combined capabilities of our two leading organizations, we will transform the consumer health experience and build healthier communities through a new innovative health care model that is local, easier to use, less expensive and puts consumers at the center of their care.”
- This Week in Managed Care: December 7, 2018 (ajmc.com)
Laura Joszt, Managing Editor at The American Journal of Managed Care. Welcome to This Week in Managed Care from the Managed Markets News Network
- As state awaits data from diabetes drug manufacturers, initial report highlights price increases (thenevadaindependent.com)
Pharmaceutical companies are preparing to submit their initial reports detailing why rising prices of some diabetes drugs have outpaced medical inflation, giving state officials the first detailed look into the costs associated with a disease that affects about a tenth of Nevadans...Despite a protracted legal battle...pharmaceutical manufacturers are required to submit reports...to comply with a new diabetes drug transparency law… the state released a list of 175 so-called national drug codes...manufacturers...are required to submit reports to the state detailing the factors that contributed to the price increases...
- This Week in Managed Care: November 23, 2018 (ajmc.com)
Laura Joszt, Managing Editor at The American Journal of Managed Care. Welcome to This Week in Managed Care from the Managed Markets News Network










